Detection of interleukin-8 on tissue array of non-small cell lung cancer and its clinicopathological significance

Chinese Journal of Lung Cancer

Volumn 10, Issue 5, 2007, Pages 386-390

  Xu, Chengping ^a   Bian, Xiuwu ^b   Wang, Qingliang ^b   Zhang, Rong ^b   Chen, Chunyan ^b   Ye, Qingwei ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Angiogenesis; Interleukin 8; Non small cell lung cancer; Tissue array

Indexed keywords

INTERLEUKIN 8;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITY; DISEASE SEVERITY; FEMALE; GENDER; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; PATHOLOGY; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

EID: 35948939332     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. + CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther, 2006, 112(1) : 139-149.
2. Strieter RM, Belperio JA, Burdick MD, et al. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann N Y Acad Sci,2004,1028 : 351-360.
3. Boldrini L, Gisfredi S, Ursino S, et al. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Lung Cancer, 2005,50(3) : 309-317.
4. Yuan A, Yang PC, Yu CJ, et al. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med, 2000, 162(5) : 1957-1963.
5. Wang QL, Bian XW, Zhang R, et al. Construction of tissue microarray with astrocytic tumor microvessels of human brain. Acta Acad Med Mil Tert, 2006,28(9) : 886-888.
6. Isobe T, Herbst RS, Onn A. Current management of advanced non-small cell lung cancer: targeted therapy. Semin Oncol, 2005, 32(3) : 315-328.
7. Yuan A, Chen JJ, Yao PL, et al. The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci, 2005, 10 : 853-865.
8. Christensen JG, Vincent PW, Klohs WD, et al. Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol Cancer Ther, 2005,4(6) : 938-947.
9. Kaminska J, Kowalska M, Kotowicz B, et al. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF: an independent prognostic factor. Oncology, 2006,70(2) : 115-125.
10. Zhu YM, Webster SJ, Flower D, et al. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer, 2004, 91 (11) : 1970-1976.
11. Yao PL, Lin YC, Wang CH, et al. Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells. Am J Respir Cell Mol Biol, 2005,32(6) : 540-547.
12. Li A, Dubey S, Varney ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol, 2003,170(6) : 3369-3376.
13. Mizukami Y, Jo WS, Duerr EM, et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med, 2005,11(9) : 992-997.
14. Yuan A, Yu CJ, Luh KT, et al. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol, 2002,20(4) : 900-910.
15. Zhang W, Stoehlmacher J, Park DJ, et al. Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clin Colorectal Cancer, 2005,5(2) : 124-131.